文献速递甲状腺与颈部外科围术期管理与 ERAS

原发性甲状旁腺功能亢进患者冠状动脉疾病更严重

Coronary artery disease is more severe in patients with primary hyperparathyroidism.
PubMed 文献 · Surgery · 2019-10-24

本研究为横断面研究,纳入130例无冠心病、糖尿病或严重慢性肾病的原发性甲状旁腺功能亢进患者,通过冠状动脉钙化评分与人群对照比较。结果发现患者平均钙化评分为120±344,21%患者评分>100,阳性评分处于对照人群的第67百分位(P<.001)。年龄、轻度正常血钙组和需用降压药是评分>100的独立预测因素。

要点

  • 原发性甲状旁腺功能亢进患者冠状动脉钙化负担高于一般人群。
  • 约21%患者冠状动脉钙化评分>100,提示中高危风险。
  • 年龄、正常血钙型及需降压药是严重钙化的独立预测因素。

核心结论

  • 原发性甲状旁腺功能亢进患者的阳性冠状动脉钙化评分高于人群对照。
  • 研究数据可能为甲状旁腺切除术提供新的手术指征标准。

研究设计与样本

  • 横断面研究,纳入130例无冠心病、糖尿病或严重慢性肾病的原发性甲状旁腺功能亢进患者。
  • 冠状动脉钙化评分与人群对照队列进行比较。

主要发现

  • 患者平均冠状动脉钙化评分为120±344。
  • 27例(21%)患者冠状动脉钙化评分>100。
  • 患者阳性钙化评分比例为53%,对照组为50%,但患者阳性评分位于对照人群的第67百分位(P<.001)。

临床怎么用

  • 对原发性甲状旁腺功能亢进患者应关注冠状动脉钙化评估。
  • 高龄、正常血钙型及需降压药的患者可能需更积极干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary hyperparathyroidism is associated with an increased cardiovascular mortality, but mechanisms underlying this association are unclear. The goal of this study was to evaluate coronary artery calcifications via the coronary calcification score in primary hyperparathyroidism patients, to compare with control subjects, and to identify risk factors for high to intermediate risk coronary calcification scores (coronary calcification score >100). METHOD: Cross-sectional study of primary hyperparathyroidism patients without a history of coronary artery disease, diabetes, or severe, chronic kidney disease. Coronary calcification scores were compared with a cohort of population-based control subjects. RESULTS: The mean coronary calcification score was 120 ± 344 in 130 primary hyperparathyroidism patients. The coronary calcification score was >100 in 27 patients (21%). When compared with control subjects, the percentage of positive coronary calcification scores was similar in primary hyperparathyroidism patients (53% vs 50%); however, positive coronary calcification scores were at the 67th percentile of the control subjects cohort (P < .001). In multivariable regression, patient age (1.1; 1.1-1.2; P < .001), patients in the mild normocalcemic primary hyperparathyroidism group (5.1; 1.1-22.6; P = .037), and the need for antihypertensive medications (6.1; 1.8-20.9; P < .001) remained independent predictors for a coronary calcification score >100. CONCLUSION: Positive coronary calcification scores were greater in primary hyperparathyroidism patients than in population-based control subjects. These study data may provide new criteria for parathyroidectomy in patients with primary hyperparathyroidism.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Koubaity O, Mandry D, Nguyen-Thi PL, et al. Coronary artery disease is more severe in patients with primary hyperparathyroidism. Surgery. 2019. PMID: 31668778. doi:10.1016/j.surg.2019.05.094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。